Clinical Trials on Filarial Infection in Mexico

Total 1240 results

Hospital Reg. Lic. Adolfo Lopez Mateos
Instituto de Terapia Celular: ITC

Unknown

Mesenchymal Stem Cells in Patients Diagnosed With COVID-19

Covid19

Mexico
Hospital Reg. Lic. Adolfo Lopez Mateos

Unknown

Outpatient Treatment With CoVid-19 With Prexablu

Sars Cov 2

Mexico
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Dengue

Mexico
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Mexico
Meridian Bioscience, Inc.

Completed

Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains

Streptococcus Agalactiae Infection

Canada, United States
Mexican Society of Public Health
Merck Sharp & Dohme LLC

Not yet recruiting

Serological Study of Dengue and Characterization of Immune Response in Ten Endemic and Non-Endemic Cities in Mexico

Dengue

Mexico
Luis Eduardo Morales Buenrostro

Completed

Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

Kidney Transplantation | Pharmacokinetics | Cytomegalovirus Infections | Therapeutic Equivalency

Mexico
National Institute of Respiratory Diseases, Mexico

Completed

Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study

Covid19

Mexico
Centro Medico ABC

Terminated

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

Covid-19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Peripheral Arterial Insufficiency Associated With HIV/AIDS (AIHIV)

Acquired Immunodeficiency Syndrome | HIV | Arterial Insufficiency

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Instituto Nacional de Medicina Genomica

Completed

Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.

Cancer | Covid19 | Tumor

Mexico
Hospital General de Mexico

Completed

Association of the Neutrophil/Lymphocyte Ratio With Pulmonary Complications and Mortality in COVID-19 Patients

Covid19 | Pulmonary Complication

Mexico
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
Hospital Central Militar

Completed

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease (PC-COVID-HCM)

Severe COVID-19 Disease

Mexico
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) (PHYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
Unidad Temporal COVID-19 en Centro Citibanamex
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Completed

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 (ANTIOX-COVID)

Pneumonia, Viral | Covid19 | Oxidative Stress | ARDS

Mexico
Hospital General Ajusco Medio
Horacio Marquez-Gonzalez; Carlos Torruco-Sotelo; Sebastian Rodriguez-Llamazares

Completed

Risk Factors for Barotrauma in COVID-19

Covid19 | Barotrauma

Mexico
Escuela Militar de Graduados de Sanidad, SEDENA

Completed

Effect of Vitamin D Supplementation on Glutathione Peroxidase (GPx) Activity, Interleukin-6 (IL-6) Levels and Clinical Outcomes in Post-COVID-19 Patients (VITDPOSTCOVID)

Post-COVID19 Condition

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Outcomes of Patients With COVID-19 in the Intensive Care Unit (MexCOVID-19)

Coronavirus Infections | COVID-19 | Viral Pneumonia Human Coronavirus

Mexico
GlaxoSmithKline

Completed

Bioequivalence Study for an Isotretinoin

Skin Infections (Acne)

Mexico
Instituto Nacional de Enfermedades Respiratorias

Unknown

Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis (VitaminD)

Pulmonary Tuberculosis

Mexico
Laboratorios Silanes S.A. de C.V.

Completed

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (DMMETCOV19-2)

Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Unknown

Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 (oXAKI-COV)

Covid19 | AKI

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Recruiting

Continuous Glucose Monitorization in Hospitalized Patients With COVID-19

Diabetes Mellitus | Covid19

Mexico
Hospital General de México Dr. Eduardo Liceaga
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; CCINSHAE... and other collaborators

Terminated

Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults (COMVIVIR)

COVID-19

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Hospital General Dr. Manuel Gea González; Instituto Nacional de Cardiologia... and other collaborators

Unknown

Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 (EPCOvid-1)

COVID-19

Mexico
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

COVID-19

Mexico
Novavax
Instituto Mexicano del Seguro Social

Completed

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Seasonal Influenza

Mexico
Universidad Panamericana

Completed

Intranasal Insulin for COVID-19-related Smell Loss

COVID-19 | Anosmia | Hyposmia | Smell Loss | Paraosmia

Mexico
Johns Hopkins Bloomberg School of Public Health
Merck Sharp & Dohme LLC

Completed

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

Haemophilus Influenzae Type B Infection

United States
National Institute of Medical Sciences and Nutrition...

Completed

COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients

Covid19

Mexico
Edda Sciutto Conde
Instituto Nacional de Cardiologia Ignacio Chavez; Hospital General de México... and other collaborators

Completed

Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19

Covid19

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Completed

Risk Factors and Computed Tomography Findings in COVID-19.

Pneumonia, Viral | Covid19 | ARDS | Computed Tomography

Mexico
Hoffmann-La Roche

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.

Hepatitis C, Chronic

Mexico
Instituto Nacional de Rehabilitacion

Enrolling by invitation

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE)

Enzyme Inhibitors | Hydroxychloroquine | Antimalarials | Antirheumatic Agents

Mexico
Hospital Civil de Guadalajara

Unknown

Metformin and Systemic Inflammation in HIV (Metfo)

PreDiabetes | HIV-1-infection

Mexico
University of New Mexico

Completed

Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures (CLNUP)

Urinary Incontinence | Pelvic Organ Prolapse | Urinary Tract Infections | Surgical Site Infection | Pelvic Floor Disorders | Gynecologic Disease | Post-Op Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Peru, Mexico
Brown University
National Institute of Mental Health (NIMH); University of California, San Francisco and other collaborators

Completed

PrEP Seguro: Antiretroviral-based HIV Prevention Among Men at High Risk in Mexico

HIV Infections

Mexico
National Institute of Cancerología
Instituto Nacional de Enfermedades Respiratorias

Completed

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Kaposi Sarcoma | Human Immunodeficiency Virus | Immune Reconstitution Syndrome

Mexico
Instituto Nacional de Enfermedades Respiratorias
Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).

Terminated

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

HIV | Tuberculosis | AIDS

Mexico
AIDS Malignancy Consortium
National Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC

Completed

Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America

HIV Infection | Malignant Neoplasm | Recurrent Malignant Neoplasm | Human Immunodeficiency Virus 1 Positive

Mexico, Argentina, Brazil
Universidad de Guanajuato

Unknown

Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%

Ventilator Associated Pneumonia | Chlorhexidine

Mexico
Coordinación de Investigación en Salud, Mexico
University College, London; Centro de Investigacion y Estudios Avanzados del... and other collaborators

Completed

Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19 (FANTAZE)

Covid19

Mexico
University of Alberta

Withdrawn

Corticosteroids for COVID-19 (CORE-COVID)

Covid19

Colombia, Mexico
Hospital Regional de Alta especialidad de Ixtapaluca
Hospital General de México Dr. Eduardo Liceaga

Completed

Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients

Covid-19

Mexico
CMN "20 de Noviembre"

Unknown

Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients

COVID-19

Mexico
CMN "20 de Noviembre"

Active, not recruiting

Estrogen Therapy in Non-severe COVID-19 Patients

Covid-19

Mexico
GlaxoSmithKline

Completed

Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children

Infections, Streptococcal

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Dengue Fever | Dengue Hemorrhagic Fever | Human Papillomavirus Disease

Mexico

Clinical Trials on Filarial Infection in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations